Literature DB >> 9619786

The quantitative analysis of crystallinity using FT-Raman spectroscopy.

L S Taylor1, G Zografi.   

Abstract

PURPOSE: To establish if FT-Raman spectroscopy can be used to quantitate the degree of crystallinity in a model compound.
METHODS: Mixtures containing different proportions of amorphous and crystalline indomethacin were prepared. Using the peak intensity ratio 1698 cm(-1) (crystalline) to 1680 cm(-1) (amorphous), a correlation curve was prepared. This correlation curve was validated by testing further samples of known composition. Partially crystalline indomethacin was prepared by milling crystalline indomethacin.
RESULTS: A linear correlation curve was obtained across the entire range of 0-100% crystallinity. Using this method, it was possible to detect down to either 1% amorphous or crystalline content. The largest errors were found to result from inhomogeneities in the mixing of the calibration and validation samples. The spectra of the mechanically processed samples were similar to the spectra of the calibration samples, and the degree of crystallinity could be estimated in these samples.
CONCLUSIONS: FT-Raman spectroscopy is a potentially useful method to complement existing techniques for the quantitative determination of crystallinity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619786     DOI: 10.1023/a:1011979221685

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Mechanical activation of pharmaceutical systems.

Authors:  R Hüttenrauch; S Fricke; P Zielke
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

2.  The qualitative and quantitative analysis of chlorpropamide polymorphic mixtures by near-infrared Fourier transform Raman spectroscopy.

Authors:  A M Tudor; S J Church; P J Hendra; M C Davies; C D Melia
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

3.  Automated system for the on-line monitoring of powder blending processes using near-infrared spectroscopy. Part I. System development and control.

Authors:  P A Hailey; P Doherty; P Tapsell; T Oliver; P K Aldridge
Journal:  J Pharm Biomed Anal       Date:  1996-03       Impact factor: 3.935

4.  Estimation of the degree of crystallinity in digoxin by X-ray and infrared methods.

Authors:  D B Black; E G Lovering
Journal:  J Pharm Pharmacol       Date:  1977-11       Impact factor: 3.765

5.  Near-infrared spectroscopic characterization of pharmaceutical powder blends.

Authors:  D J Wargo; J K Drennen
Journal:  J Pharm Biomed Anal       Date:  1996-08       Impact factor: 3.935

6.  Quantitative FT-Raman analysis of two crystal forms of a pharmaceutical compound.

Authors:  F W Langkilde; J Sjöblom; L Tekenbergs-Hjelte; J Mrak
Journal:  J Pharm Biomed Anal       Date:  1997-03       Impact factor: 3.935

Review 7.  Characteristics and significance of the amorphous state in pharmaceutical systems.

Authors:  B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1997-01       Impact factor: 3.534

8.  Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding.

Authors:  M Otsuka; T Matsumoto; N Kaneniwa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-04       Impact factor: 1.645

9.  Quantitation of cefepime.2HCl dihydrate in cefepime.2HCl monohydrate by diffuse reflectance IR and powder X-ray diffraction techniques.

Authors:  D E Bugay; A W Newman; W P Findlay
Journal:  J Pharm Biomed Anal       Date:  1996-10       Impact factor: 3.935

10.  Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions.

Authors:  L S Taylor; G Zografi
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

View more
  23 in total

1.  Confocal Raman-spectroscopy: analytical approach to solid dispersions and mapping of drugs.

Authors:  J Breitenbach; W Schrof; J Neumann
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Detection of low levels of the amorphous phase in crystalline pharmaceutical materials by thermally stimulated current spectrometry.

Authors:  G M Venkatesh; M E Barnett; C Owusu-Fordjour; M Galop
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

3.  Crystal nucleation and growth of spherulites demonstrated by coral skeletons and phase-field simulations.

Authors:  Chang-Yu Sun; László Gránásy; Cayla A Stifler; Tal Zaquin; Rajesh V Chopdekar; Nobumichi Tamura; James C Weaver; Jun A Y Zhang; Stefano Goffredo; Giuseppe Falini; Matthew A Marcus; Tamás Pusztai; Vanessa Schoeppler; Tali Mass; Pupa U P A Gilbert
Journal:  Acta Biomater       Date:  2020-06-23       Impact factor: 8.947

4.  Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and x-ray powder diffractometry.

Authors:  Makoto Otsuka; Fumie Kato; Yoshihisa Matsuda; Yukihiro Ozaki
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

5.  Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry.

Authors:  Cletus Nunes; Arumugam Mahendrasingam; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2005-08-31       Impact factor: 4.200

6.  Identifying and mapping surface amorphous domains.

Authors:  Stuart Ward; Mark Perkins; Jianxin Zhang; Clive J Roberts; Claire E Madden; Shen Y Luk; Nikin Patel; Stephen J Ebbens
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

7.  Quantitative measurement of indomethacin crystallinity in indomethacin-silica gel binary system using differential scanning calorimetry and X-ray powder diffractometry.

Authors:  Xiaohong Pan; Thomas Julian; Larry Augsburger
Journal:  AAPS PharmSciTech       Date:  2006-02-10       Impact factor: 3.246

8.  Effect of physical state and particle size distribution on dissolution enhancement of nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation.

Authors:  George Z Papageorgiou; Dimitrios Bikiaris; Evagelos Karavas; Stavros Politis; Aristides Docoslis; Yong Park; Anagnostis Stergiou; Emmanouel Georgarakis
Journal:  AAPS J       Date:  2006-10-06       Impact factor: 4.009

9.  Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy.

Authors:  Takehiro Okumura; Makoto Otsuka
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

10.  Nonlinear optical imaging for sensitive detection of crystals in bulk amorphous powders.

Authors:  Umesh S Kestur; Duangporn Wanapun; Scott J Toth; Lindsay A Wegiel; Garth J Simpson; Lynne S Taylor
Journal:  J Pharm Sci       Date:  2012-07-30       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.